Preliminary research indicate conolidine could inhibit particular ion channels, lowering neuronal excitability and restricting suffering indicators. This system is especially relevant in neuropathic suffering, where abnormal signaling leads to persistent pain. On top of that, conolidine seems to influence G protein-coupled receptor (GPCR) pathways